Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This new test could “play an important role” in screening people who are at risk for developing hepatocellular carcinoma.
A third of patients treated with Opdivo plus Yervoy experienced complete or partial tumor remission.
It involves the buildup of fat in the liver.
Houstonian Terri Milton is determined not to let advanced fatty liver disease get the best of her.
Learn more about how NAFLD progresses and eventually leads to worsening liver damage.
A triple regimen of Opdivo, Yervoy and Cabometyx showed good activity, but side effects may limit its use.
Transplants due to hepatitis C have declined dramatically thanks to effective treatment.
Those with fatty liver disease and cirrhosis should undergo regular screening.
Tecentriq plus Avastin improved improved overall survival and patient experiences during treatment.
The LIVER Act would increase funding for liver cancer and hepatitis B research and prevention.
Curing hep C slashes risk of death for those with liver cancer history
Smoking cessation, a healthy diet, exercise and weight loss could dramatically reduce new liver cancer cases and liver disease deaths.
Sustained response to direct-acting antivirals prolonged survival by a year and a half.
People treated with Viread, Vemlidy or Baraclude are less likely to develop this malignancy.
Opdivo plus Yervoy led to higher response rates and longer survival than Opdivo alone.
A new study shows that people with the liver disease have substantial financial burden that can impact their care.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.